0
Business
Obesity Treatment Firm Kailera Upsizes IPO to Raise $625 Million
April 16, 2026
Scroll
Posted 3 hours ago by
Kailera Therapeutics Inc., a clinical-stage biotechnology company focused on obesity, raised 625 million in an upsized initial public offering, marking the sector’s biggest US listing since 2021.
Bloomberg
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.